Suppr超能文献

口服维甲酸类药物治疗蕈样肉芽肿和塞扎里综合征:异维甲酸和阿维A酯的比较。斯堪的纳维亚蕈样肉芽肿研究组的一项研究。

Oral retinoids in mycosis fungoides and Sézary syndrome: a comparison of isotretinoin and etretinate. A study from the Scandinavian Mycosis Fungoides Group.

作者信息

Molin L, Thomsen K, Volden G, Aronsson A, Hammar H, Hellbe L, Wantzin G L, Roupe G

出版信息

Acta Derm Venereol. 1987;67(3):232-6.

PMID:2442936
Abstract

Thirty-nine patients with mycosis fungoides in various stages or Sézary syndrome were treated with isotretinoin and 29 with etretinate as single drug therapy. Complete remission within 2 months was obtained with isotretinoin in 8 cases (21%) and partial remission in another 15 cases (38%). Etretinate induced complete remission in 5 cases (21%) and partial remission in 11 (46%). Only 1 case with Sézary syndrome went into partial remission. The first sign of remission occurred in 2 to 4 weeks. During continued treatment remissions could not always be maintained. Isotretinoin and etretinate were considered to be of equal potency in the treatment of mycosis fungoides.

摘要

39例处于不同阶段的蕈样肉芽肿或 Sézary 综合征患者接受异维甲酸单药治疗,29例患者接受依曲替酯单药治疗。异维甲酸治疗2个月内,8例(21%)获得完全缓解,另外15例(38%)获得部分缓解。依曲替酯诱导5例(21%)完全缓解,11例(46%)部分缓解。仅1例 Sézary 综合征患者获得部分缓解。缓解的首个迹象出现在2至4周。在持续治疗期间,缓解并非总能维持。异维甲酸和依曲替酯在蕈样肉芽肿治疗中被认为效力相当。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验